Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Devanshi Jain
Institution:
Dayanand Medical College & Hospital
Observed institutions:
Dayanand Medical College & Hospital,
Punjab Technical University
ORCID:
0000-0003-2345-4948
Observed ORCID:
0000-0003-2345-4948
OpenAlex ID:
A5103227320
Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs)
2023
·
Devanshi Jain
, Gazal Sharma
, et al.
·
Expert Opinion on Drug Safety
·
24
Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
2024
·
Arshdeep Singh
, Arshia Bhardwaj
, et al.
·
Intestinal Research
·
14
PDF
Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis
2025
·
Arshdeep Singh
, Arshia Bhardwaj
, et al.
·
Alimentary Pharmacology & Therapeutics
·
7
Clinical spectrum of acute severe ulcerative colitis in the biologic era: a prospective cohort study from India
2025
·
Arshdeep Singh
, Mayur Luthra
, et al.
·
Intestinal Research
·
7
PDF
Effectiveness and Safety of Tofacitinib in Biologic-naïve Elderly Patients With Ulcerative Colitis
2025
·
Arshdeep Singh
, Arshia Bhardwaj
, et al.
·
Clinical Gastroenterology and Hepatology
·
3
Endo-histologic outcomes in patients with ulcerative colitis responding to tofacitinib
2025
·
Arshdeep Singh
, Arshia Bhardwaj
, et al.
·
Indian Journal of Gastroenterology
·
2
Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis
2026
·
Arshdeep Singh
, Arshia Bhardwaj
, et al.
·
Scientific Reports
·
1
PDF
Show more works
View as search
Works count:
7
Citation count:
58
H-index:
4
I10-index:
2
Year
Topic
Type